The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...results at the national, regional and global levels.
This publication updates the WHO HIVResNet HIV drug resistance laboratory operational framework published in 2017 and reflects technical and strategic developments over the past three years.
more
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ...Organization (WHO) guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities relate to general measures (that is, the core components of infection prevention and control [IPC] programmes) that need to be in place in all countries and health care facilities to prevent and control health care-associated infections (HAIs). The use of a stepwise approach is proposed to support implementation and improvement, based on the evidence and experience of what has worked in several health care settings worldwide. The focus is on adoptable and adaptable information.
more
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi...dwives, nurses, general medical practitioners, obstetricians, obstetric physicians, managers of maternal and child health programmes, and relevant staff in ministries of health, in all settings.
more
This document provides an overview of specific health care waste technologies for the treatment of solid infectious and sharp waste. For each technology, details of its operation, effects on the environment and health, requirements for installation, capacities for treating waste, examples of consuma...bles and advantages and disadvantages are described. The document is designed for health care facility administrators and planners, WASH and infection prevention control staff, national planners, donors and partners.
more
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not to use corticosteroids in the treatment of patients ...with non-severe COVID-19 as the treatment brought no benefits, and could even prove harmful. Treatment should be under supervision of a clinician.
Corticosteroids are listed in the WHO model list of essential medicines, readily available globally at a low cost. WHO encourages countries to maintain sufficient stocks of corticosteroids to treat COVID-19 and the other disease for which they are effective, while not maintaining excessive stocks which could deny other countries access.
more
The pandemic presents tough choices for governments, local communities, health and school systems, as well as families and businesses: How to re-open safely? How to safeguard people’s lives and protect their livelihoods? Where to allocate scarce resources? How to protect those unable to protect th...emselves? Answers to questions like these will affect our short-term success in battling the spread of the virus and could have impacts for generations to come.
More than ever, the world needs reliable and trustworthy data and statistics to inform these important decisions. The United Nations and all member organizations of the Committee for the Coordination of Statistical Activities (CCSA) collect and make available a wealth of information for assessing the multifaceted impacts of the pandemic. This report updates some of the global and regional trends presented in Volume I and offers a snapshot of how COVID-19 continues to affect the world today across multiple domains.
more
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
This third regional report discusses gaps and challenges in reducing the harmful use of alcohol and how countries can reverse current trends in a cost-effective and expedited way.
This third edition of the landscape analysis provides regional and country-specific data. This report illustrates the complexities in surveillance of influenza and other respiratory viruses and highlights differences in the countries’ preparedness capacities through charts, infographics, tables, a...nd brief narratives.
more
This new edition highlights once again the importance of collecting disaggregated data to conduct gender-based analysis in order to determine, address, reduce, and eliminate the causes of gender-related inequalities.
Orientação provisória. 2 de setembro de 2020
Questão clínica: Qual é o papel dos corticosteroides sistêmicos no tratamento de pacientes com COVID-19? Público-alvo: O público-alvo consiste principalmente de médicos, seguido por tomadores de decisão na área de saúde.
Versión abreviada. En esta versión abreviada de las Directrices de práctica clínica basadas en la evidencia para el seguimiento de recién nacidos en riesgo se brindan recomendaciones para la atención de recién nacidos hasta los 2 años y corresponden a la primera fase de su seguimiento. Las r...ecomendaciones están dirigidas a todos los funcionarios del sector de la salud responsables de la atención primaria de estos recién nacidos: médicos generales, médicos de familia, pediatras, neonatólogos, oftalmólogos pediatras, otorrinolaringólogos pediatras, profesionales de enfermería, especialistas en otros campos y personal multidisciplinario que interviene en el proceso de atención
more
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Con esta guía de referencia rápida podrán reconocer con facilidad las enfermedades y efectos secundarios relacionados con el cambio climático, administrar los tratamientos adecuados y aconsejar a las poblaciones expuestas, presentar información actualizada sobre la relación entre los efectos s...ecundarios de ciertos medicamentos y la agravación de las dolencias sensibles al clima, y determinar las consecuencias posibles para los servicios de salud. En este libro se abordan los principales fenómenos meteorológicos, así como las afecciones en las que pueden tener incidencia, agrupados por áreas clínicas específicas.
more
В настоящем документе представлен первоначальный обзор поступающей информации
(по состоянию на 2 июля 2020 г.) о взаимосвязи между COVID-19, НИЗ и факторами
риска НИЗ. Ре...цензируемые статьи взяты из баз данных NCBI PubMed, PMC и Google
Scholar. Данный обзор свидетельствует о том, что лица, живущие с НИЗ, подвержены
более высокому риску развития тяжелого заболевания и смерти в связи с COVID-19,
и об ограниченности данных для оценки риска. Наряду с этим в нем обобщаются
результаты двух проведенных ВОЗ обследований, указывающих на то, что с началом
пандемии была серьезно нарушена система предоставления услуг по профилактике и
лечению НИЗ.
Response to non-communicable diseases during and after the COVID-19 pandemic
more
Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity and draws conclusions relevant to the further implementation of the Convention.
GBO-5 provi...des global summary of progress towards the Aichi Biodiversity Targets and is based on a range of indicators, research studies and assessments (in particular the IPBES Global Assessment on Biodiversity and Ecosystem Services), as well as the national reports provided by countries on their implementation of the CBD. The national reports provide rich information about the steps taken in countries worldwide in support of biodiversity conservation, sustainable use, and the fair and equitable sharing of benefits. This body of Information provides a wealth of information on the successes and challenges in implementing the Strategic Plan for Biodiversity 2011-2020 and in reaching the Aichi Biodiversity Targets.
This Outlook draws on the lessons learned during the first two decades of this century to clarify the transitions needed if we are to realize the vision agreed by world governments for 2050, ‘Living in Harmony with Nature’. You can download the report in several languages
more
La Perspectiva Mundial sobre la Diversidad Biológica (PMB) es la principal publicación del Convenio sobre la Diversidad Biológica (CDB). Se trata de un informe periódico que resume los datos más recientes sobre la situación y las tendencias de la biodiversidad y extrae conclusiones pertinentes... para la aplicación ulterior del Convenio.
La GBO-5 ofrece un resumen global de los progresos realizados en la consecución de las Metas de Aichi para la Diversidad Biológica y se basa en una serie de indicadores, estudios de investigación y evaluaciones (en particular la Evaluación Mundial de la Diversidad Biológica y los Servicios de los Ecosistemas de la IPBES), así como en los informes nacionales presentados por los países sobre su aplicación del CDB. Los informes nacionales proporcionan una rica información sobre las medidas adoptadas en los países de todo el mundo en apoyo de la conservación de la biodiversidad, el uso sostenible y el reparto justo y equitativo de los beneficios. Este conjunto de información proporciona una gran cantidad de información sobre los éxitos y los desafíos en la aplicación del Plan Estratégico para la Diversidad Biológica 2011-2020 y en la consecución de las Metas de Aichi para la Diversidad Biológica.
Esta Perspectiva se basa en las lecciones aprendidas durante las dos primeras décadas de este siglo para aclarar las transiciones necesarias si queremos hacer realidad la visión acordada por los gobiernos del mundo para 2050, "Vivir en armonía con la naturaleza".
more
Les Perspectives mondiales de la biodiversité (PMB) sont la publication phare de la Convention sur la diversité biologique (CDB). Il s'agit d'un rapport périodique qui résume les dernières données sur l'état et les tendances de la biodiversité et tire des conclusions pertinentes pour la pour...suite de la mise en œuvre de la Convention.
Le GBO-5 fournit un résumé mondial des progrès accomplis en vue de la réalisation des objectifs d'Aichi en matière de biodiversité et se fonde sur une série d'indicateurs, d'études de recherche et d'évaluations (en particulier l'évaluation mondiale de la biodiversité et des services écosystémiques de l'IPBES), ainsi que sur les rapports nationaux fournis par les pays sur leur mise en œuvre de la CDB. Les rapports nationaux fournissent de riches informations sur les mesures prises dans les pays du monde entier en faveur de la conservation de la biodiversité, de son utilisation durable et du partage juste et équitable des avantages. Ce corpus d'informations fournit une foule de renseignements sur les réussites et les difficultés de la mise en œuvre du Plan stratégique pour la biodiversité 2011-2020 et de la réalisation des objectifs d'Aichi en matière de biodiversité.
Ces Perspectives s'appuient sur les enseignements tirés des deux premières décennies de ce siècle pour clarifier les transitions nécessaires si nous voulons concrétiser la vision convenue par les gouvernements mondiaux pour 2050, "Vivre en harmonie avec la nature".
more